Bimini Capital extends poison pill to 2030, raises purchase price to $10.20 to protect NOLs

BIMINI CAPITAL MANAGEMENT, INC.

Rights plan expiration extended five years to December 21, 2030.
Purchase price per right increased from $4.76 to $10.20.
Aims to protect ~$253.9M in net operating loss carryforwards under Section 382.
Amendment subject to stockholder approval at 2026 annual meeting; terminates if not approved by June 30, 2026.

item 1.01 item 3.03 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

BIMINI CAPITAL MANAGEMENT, INC. issued unit.

Security: unit

Exact text from the filing

The First Amendment extends the expiration date of the Rights (as defined in the Rights Agreement) until December 21, 2030. The First Amendment also increases the Purchase Price (as defined in the Rights Agreement) from $4.76 to $10.20.

View on SEC.gov

30 equity issuances filed in the last 30 days. Browse all equity issuances →

BIMINI CAPITAL MANAGEMENT, INC. filing history →

Source: SEC EDGAR

accession 0001437749-25-037399

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.